U.S. Blood Pressure Monitoring Devices Market (By Product: Digital Blood Pressure Monitor, Sphygmomanometer, Ambulatory Blood Pressure Monitor, Instruments & Accessories, Transducers; By End User: Ambulatory Surgical Centers & Clinics, Hospitals, Home Healthcare) - Regional Outlook and Forecast 2024 to 2033
The U.S. blood pressure monitoring devices market size was valued at USD 0.52 billion in 2023 and is anticipated to reach around USD 1.48 billion by 2033, expanding at a double-digit CAGR of 11.10% from 2024 to 2033.
Access our Healthcare Data Intelligence Tool with 10000+ Database, Visit: Towards Healthcare
The U.S. blood pressure monitoring devices market revolves around the development and distribution of monitoring devices that are generally to measure pulse inside the arteries using blood pressure as a parameter. To test, treat, and keep an eye on hypertension, blood pressure monitoring devices are essential. Pulse monitoring devices are incredibly accurate and assist physicians or other professionals in ensuring effective care. These incredibly accurate devices assist medical professionals in providing patients with efficient care.
Report Coverage | Details |
Growth Rate from 2024 to 2033 | CAGR of 11.10% |
U.S. Market Size in 2023 | USD 0.52 Billion |
U.S. Market Size by 2033 | USD 1.48 Billion |
Base Year | 2023 |
Forecast Period | 2024 to 2033 |
Segments Covered | By Product and By End User |
Driver
Rising older population and awareness about hypertension
The likelihood of hypertension seems to rise with age. Older people are more likely to have high blood pressure because of hormonal fluctuations and altered blood vessel flexibility. As a result, the need for blood pressure monitoring devices is being driven by the demographic trend toward an older population. Elderly people's blood pressure is being monitored and managed by healthcare practitioners more often with the prescription of these devices. Further boosting the U.S. blood pressure monitoring devices market’s expansion is the fact that a large number of senior citizens find home blood pressure monitoring to be more convenient.
Additionally, people are more likely to routinely check their blood pressure as they become more aware of the dangers of hypertension and how it affects their general health. Investing in personal blood pressure monitoring devices is encouraged by the focus on early identification and preventative healthcare. Furthermore, a greater number of prescriptions are being written as a result of healthcare professionals actively teaching patients about the advantages of monitoring. Device sales are fueled by this increased knowledge and health consciousness, which also improves health outcomes by enabling early intervention and lifestyle changes in reaction to rising blood pressure readings.
Restraint
The presence of high undiagnosed population
The greatest contributor to the burden of illnesses and the main cause of heart attacks is hypertension. A sizable segment of the populace received insufficient care or no diagnosis at all. As a result, they have a higher chance of morbidity and death from diseases like stroke and other CVDs that are associated with hypertension.
Healthcare professionals (HCPs) are encouraged to identify people who may have undetected hypertension as part of this effort. The new hypertension threshold, established by the American Heart Association (AHA) and the American College of Cardiology (ACC), is 130/80 mm Hg. It was 140/80 mm Hg before. Over 103 million Americans now have high blood pressure as a result of the reclassification. As a result, the large number of undiagnosed people poses a barrier to the expansion of the blood pressure monitoring device industry in the United States.
Opportunity
Rising demand for ambulatory blood pressure monitoring systems
Ambulatory blood pressure monitors are becoming more and more in demand, mainly for the diagnosis of white coats and disguised hypertension. Ambulatory blood pressure monitors are small, wrist- or arm-based devices with features that make them easier to use and more accessible. Ambulatory BP monitoring technologies allow for noninvasive blood pressure measurement. When people engage in regular activities, their blood pressure may be monitored by the use of ambulatory blood pressure monitors.
These gadgets keep an eye on how well blood pressure meds are working. The diagnosis of arterial hypertension is done at home and medical institutions like clinics using ambulatory blood pressure monitors. Advanced ambulatory blood pressure monitors are available from several companies. Thus, throughout the projected period, the U.S. blood pressure monitoring devices market will rise due to the rising demand for ambulatory BP monitoring systems.
The sphygmomanometer segment held the largest share of the U.S. blood pressure monitoring devices market in 2023 due to its accuracy and reliability. Sphygmomanometers are known for their accuracy in measuring blood pressure. This accuracy is crucial for making informed clinical decisions and diagnosing conditions such as hypertension. This remains a staple in clinical settings such as hospitals, clinics, and healthcare offices. They provide accurate blood pressure measurements and are often used by medical professionals to assess patients' cardiovascular health.
Besides, the ambulatory blood pressure monitor segment is expected to grow at the fastest CAGR during the forecast period. Ambulatory blood pressure monitor devices offer the advantage of continuous blood pressure monitoring, providing a more comprehensive and accurate picture of a patient's blood pressure variations throughout the day and night. This helps in identifying patterns and abnormalities that may go unnoticed with intermittent measurements.
Additionally, ABPM devices are designed to be portable and non-intrusive, allowing patients to go about their daily activities while the device records blood pressure readings at regular intervals. This ambulatory nature improves patient compliance and provides a more natural representation of their blood pressure.
The hospitals segment held the largest market share in 2023 and is expected to capture the largest market share during the forecast period. The large patient pool size is the reason for the high share. Increasingly, quick, accurate, and affordable diagnostic tools are needed to improve patient outcomes, which is why blood pressure monitoring devices are being used.
The home healthcare segment is expected to grow at the fastest rate over the projected period in the U.S. blood pressure monitoring devices market. home blood pressure monitoring devices offer convenience and accessibility, allowing individuals to monitor their blood pressure without the need for frequent visits to healthcare facilities. This is particularly beneficial for elderly individuals and those with mobility issues. Thereby, driving the segment expansion.
Segments Covered in the Report
By Product
By End User
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology (Premium Insights)
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on U.S. Blood Pressure Monitoring Devices Market
5.1. COVID-19 Landscape: U.S. Blood Pressure Monitoring Devices Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8.U.S. Blood Pressure Monitoring Devices Market, By Product
8.1. U.S. Blood Pressure Monitoring Devices Market Revenue and Volume, by Product, 2024-2033
8.1.1. Digital Blood Pressure Monitor
8.1.1.1. Market Revenue and Volume Forecast (2021-2033)
8.1.2. Sphygmomanometer
8.1.2.1. Market Revenue and Volume Forecast (2021-2033)
8.1.3. Ambulatory Blood Pressure Monitor
8.1.3.1. Market Revenue and Volume Forecast (2021-2033)
8.1.4. Instruments & Accessories
8.1.4.1. Market Revenue and Volume Forecast (2021-2033)
8.1.5. Transducers
8.1.5.1. Market Revenue and Volume Forecast (2021-2033)
Chapter 9. U.S. Blood Pressure Monitoring Devices Market, By End User
9.1. U.S. Blood Pressure Monitoring Devices Market Revenue and Volume, by End User, 2024-2033
9.1.1. Ambulatory Surgical Centers & Clinics
9.1.1.1. Market Revenue and Volume Forecast (2021-2033)
9.1.2. Hospitals
9.1.2.1. Market Revenue and Volume Forecast (2021-2033)
9.1.3. Home Healthcare
9.1.3.1. Market Revenue and Volume Forecast (2021-2033)
Chapter 10. U.S. Blood Pressure Monitoring Devices Market and Trend Forecast
10.1. U.S.
10.1.1. Market Revenue and Volume Forecast, by Product (2021-2033)
10.1.2. Market Revenue and Volume Forecast, by End User (2021-2033)
Chapter 11. Company Profiles
11.1. Koninklijke Philips N.V.
11.1.1. Company Overview
11.1.2. Product Offerings
11.1.3. Financial Performance
11.1.4. Recent Initiatives
11.2. General Electric Company
11.2.1. Company Overview
11.2.2. Product Offerings
11.2.3. Financial Performance
11.2.4. Recent Initiatives
11.3. SunTech Medical, Inc.
11.3.1. Company Overview
11.3.2. Product Offerings
11.3.3. Financial Performance
11.3.4. Recent Initiatives
11.4. Welch Allyn
11.4.1. Company Overview
11.4.2. Product Offerings
11.4.3. Financial Performance
11.4.4. Recent Initiatives
11.5. American Diagnostic Corporation
11.5.1. Company Overview
11.5.2. Product Offerings
11.5.3. Financial Performance
11.5.4. Recent Initiatives
11.6. Briggs Healthcare
11.6.1. Company Overview
11.6.2. Product Offerings
11.6.3. Financial Performance
11.6.4. Recent Initiatives
11.7. Spacelabs Healthcare
11.7.1. Company Overview
11.7.2. Product Offerings
11.7.3. Financial Performance
11.7.4. Recent Initiatives
11.8. GF HEALTH PRODUCTS, INC.
11.8.1. Company Overview
11.8.2. Product Offerings
11.8.3. Financial Performance
11.8.4. Recent Initiatives
11.9. Rossmax International Limited
11.9.1. Company Overview
11.9.2. Product Offerings
11.9.3. Financial Performance
11.9.4. Recent Initiatives
11.10. Microlife Corporation
11.10.1. Company Overview
11.10.2. Product Offerings
11.10.3. Financial Performance
11.10.4. Recent Initiatives
Chapter 12. Research Methodology
12.1. Primary Research
12.2. Secondary Research
12.3. Assumptions
Chapter 13. Appendix
13.1. About Us
13.2. Glossary of Terms
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client